NHG-Standaard 'Astma bij kinderen'

1. Bindels PJE, et al. NHG-Standaard 'Astma bij kinderen'. Huisarts Wet 2006; 49: 557-572.
2. Brand PL. Inhaled corticosteroids reduce growth. Or do they? Eur Respir J 2001; 17: 287-294.
3. Leone FT, et al. Systematic review of the evidence regarding potential complications of inhaled corticosteroid use in asthma: collaboration of American College of Chest Physicans, American Academy of Allergy, Asthma and Immunology, and American College of Allergy, Asthma and Immunology, Chest 2003; 124: 2329-2340.
4. Mushtaq T, et al. The impact of corticosteroids on growth and bone health. Arch Dis Child 2002; 87: 93-96.
5. Verberne AAPH, et al. the Dutch Paediatric Asthma Study Group. Addition of salmeterol versus doubling the dose of beclomethason in children with asthma. In: Verberne AAPH. Salmeterol in the treatment of childhood asthma [proefschrift]. Rotterdam: Erasmus Universiteit Rotterdam, 1997.
6. Mann M, et al. Serious asthma exacerbations in asthmatics treated with high dose formoterol. Chest 2003; 124: 70-74.
7. Cheung D, et al. Long-term effects of a long-acting B2-adrenoceptor agonist salmeterol, on airway hyperresponsiveness in patients with mild asthma. N Engl J Med 1992; 327: 1198-1203.
8. Verberne AAPH, et al. Airway responsiveness after a single dose of salmeterol and during four months of treatment in children with asthma. J Allergy Clin Immunol 1996; 97: 938-946.
9. Yates DH, et al. Regular formoterol treatment in mild asthma. Effect on bronchial responsiveness during and after treatment. Am J Respir Crit Care Med 1995; 152: 1170-1174.
10. Grove A, et al. Bronchodilator subsensitivity to salbutamol after twice daily salmeterol in asthmatic patients. Lancet 1995; 346: 201-206.
11. Ram FS, at al. Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma. Cochrane Database Syst Rev 2005; 1: CD003137.
12. Wouden JC van der, et al. Inhaled sodium cromoglycate for asthma in children. Cochrane database Syst Rev 2003; 3: CD002173. 


  • mw drs M.M. Verduijn